HOME >> MEDICINE >> NEWS
ESA experiments with spaceflight participant Ansari to ISS

Scheduled to lift off on 18 September 2006 from the Baikonur Cosmodrome, Kazakhstan, along with Expedition 14 crew members, NASA astronaut Michael Lopez-Alegria and Russian cosmonaut Mikhail Tyurin, Iranian-American entrepreneur Anousheh Ansari will be the test subject for four ESA experiments during her stay on board the International Space Station.

The experiments in which Ansari will participate are in the area of human physiology: from the search of the effects of space radiation on the crew, to the investigation of the mechanisms governing the development of muscle atrophy in astronauts. The experiments aim to investigate the reaction of the human organism to the space environment, with the ultimate objective of optimizing the conditions for human permanence in space, and to cast light on common diseases affecting people on Earth. The European Experiment Programme that is currently carried out by ESA on the International Space Station (ISS) covers a large range of scientific disciplines, which encompass physics, chemistry, biology, physiology, psychology and related topics.

Astronauts on board the ISS have a very busy schedule, performing every day experiments on behalf of scientists on Earth, and acting as subjects of experiments themselves.

A number of experiments - especially in the area of human physiology - fall under a long-term plan and require a high number of observations to be carried out in various sessions and on a considerable number of different subjects. For this reason such experiments involve not only the permanent crew of the ISS, currently constituting three members, but also short term visitors, who are regularly ferried to the Station with the Soyuz or with the Shuttle.

This is the case for ESA astronauts, who normally perform a series of experiments during their short missions to the ISS. In 2005, it was Spaceflight Participant Gregory Olsen who acted as a subject for ESA experiments in the
'"/>

Contact: Maurizio Belingheri
maurizio.belingheri@esa.int
31-071-565-4687
European Space Agency
12-Sep-2006


Page: 1 2 3 4

Related medicine news :

1. Grueling four-day race becomes Stanford lab for cardiac experiments
2. Melanoma vaccine strategy shows promise in laboratory experiments
3. Researchers find that chocolate compound stops cancer cell cycle in lab experiments
4. Flavanol-rich cocoa improves blood vessel function in aging baby boomer study participants
5. Diabetes program demonstrates comprehensive care approach to NYC participants
6. Sharing clinical trial results strongly favored by participants
7. IOF announces Strong Bones Strong Women participants
8. Premature baby ventilation trial cleared of causing long-term harm to participants
9. Disclosing study outcomes to participants may backfire
10. Jewelry-making program empowers participants, reduces HIV risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ESA experiments with spaceflight participant Ansari ISS

(Date:5/18/2013)... There are significant cost and risk factors ... or treat gastrointestinal problems, according to research presented ... study by New York Presbyterian Hospital and Weill-Cornell ... substantially reduce the cost and risk of managing ... to affect nearly 25 percent of adults, researchers ...
(Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) A ground-breaking ... colorectal care, according to research presented today at ... optimizing the minimal withdrawal time for colonoscopies and ... , During colonoscopy, doctors use a device called ... test for colorectal cancer allows a doctor to ...
(Date:5/18/2013)... New York (PRWEB) May 18, 2013 ... pelvic mesh products continue to move forward in a ... Court, Bernstein Liebhard LLP reports. According to a notice ... in the Ethicon pelvic mesh litigation will be held ... 2,755 complaints have been filed in the proceeding on ...
(Date:5/18/2013)... By Serena Gordon HealthDay Reporter , , FRIDAY, May ... college students sometimes binge drink, but new research shows that ... alcohol on a weekly basis than are college men. ... of alcohol that,s considered safe on a weekly basis is ... drinks for women versus 14 for men. But, there,s good ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3
(Date:5/17/2013)... JERUSALEM , May 17, 2013 ... a developer of oral drug delivery systems, announced today ... has cleared the Company,s Investigational New Drug application(IND) for ... very pleased to have the FDA clearance to proceed," ... Oramed. "The upcoming trial is a major milestone for ...
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
Cached News: